{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:39:03Z","timestamp":1791085143745,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cgh.2014.08.042","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T10:47:02Z","timestamp":1411123622000},"page":"940-948.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Adalimumab for the Treatment of Japanese Patients With Intestinal Beh\u00e7et\u2019s Disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Satoshi","family":"Tanida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagamu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunei","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Mitsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Nagahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Motoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopal B.","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2014.08.042_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-7-20","article-title":"Beh\u00e7et's disease","volume":"7","author":"Saadoun","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib2","article-title":"Guidebook for Beh\u00e7et's disease","author":"Matsuda","year":"2002","journal-title":"Nihonigakukan"},{"key":"10.1016\/j.cgh.2014.08.042_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Beh\u00e7et's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cgh.2014.08.042_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02604297","article-title":"Intestinal involvement in Beh\u00e7et's disease: review of 136 surgical cases in the Japanese literature","volume":"24","author":"Kasahara","year":"1981","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2014.08.042_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.08.042_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/imt.13.66","article-title":"Approaches to immunosuppression in Beh\u00e7et's disease","volume":"5","author":"Comarmond","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cgh.2014.08.042_bib7","first-page":"60","article-title":"Indications for surgery in intestinal Beh\u00e7et's disease","volume":"53","author":"Kurata","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2014.08.042_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/ibd.21517","article-title":"Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Beh\u00e7et's disease","volume":"17","author":"Jung","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-\u03b1, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et's disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cgh.2014.08.042_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0974-9233.58425","article-title":"Beh\u00e7et's uveitis","volume":"16","author":"Tugal-Tutkun","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.cgh.2014.08.042_bib11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ibd.20869","article-title":"Intestinal Beh\u00e7et's disease: maintenance of remission with adalimumab monotherapy","volume":"15","author":"Ariyachaipanich","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10350-006-0813-x","article-title":"Antitumor necrosis factor-\u03b1 therapy for early postoperative recurrence of gastrointestinal Beh\u00e7et's disease: report of a case","volume":"50","author":"Byeon","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2014.08.042_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kep126","article-title":"Effects of anti-TNF-\u03b1 antibody infliximab in refractory entero-Beh\u00e7et's disease","volume":"48","author":"Iwata","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.cgh.2014.08.042_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10067-006-0410-3","article-title":"Successful treatment of life-threatening intestinal ulcer in Beh\u00e7et's disease with infliximab: rapid healing of Beh\u00e7et's ulcer with infliximab","volume":"26","author":"Ju","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cgh.2014.08.042_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","article-title":"Beh\u00e7et's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case","volume":"46","author":"Kram","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2014.08.042_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3904\/kjim.2007.22.1.24","article-title":"Remission of intestinal Beh\u00e7et's disease treated with anti-tumor necrosis factor \u03b1 monoclonal antibody (infliximab)","volume":"22","author":"Lee","year":"2007","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.cgh.2014.08.042_bib17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ibd.20457","article-title":"Efficacy of infliximab for induction and maintenance of remission in intestinal Beh\u00e7et's disease","volume":"14","author":"Naganuma","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","article-title":"Treatment of intestinal Beh\u00e7et's syndrome with chimeric tumour necrosis factor \u03b1 antibody","volume":"49","author":"Travis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2014.08.042_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2169\/internalmedicine.52.0589","article-title":"Efficacy of infliximab in patients with intestinal Beh\u00e7et's disease refractory to conventional medication","volume":"52","author":"Kinoshita","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2014.08.042_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00535-013-0872-4","article-title":"The 2nd edition of consensus statements for the diagnosis and management of intestinal Beh\u00e7et's disease: indication of anti-TNF\u03b1 monoclonal antibodies","volume":"49","author":"Hisamatsu","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2014.08.042_bib21","series-title":"HUMIRA [package insert]","year":"2013"},{"key":"10.1016\/j.cgh.2014.08.042_bib22","series-title":"HUMIRA [summary of product characteristics]","year":"2013"},{"key":"10.1016\/j.cgh.2014.08.042_bib23","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005176-199904001-00003","article-title":"Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease","volume":"28","author":"Irvine","year":"1999","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2014.08.042_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00019053-199915020-00003","article-title":"Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II","volume":"15","author":"Samsa","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cgh.2014.08.042_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.crohns.2011.07.013","article-title":"Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease","volume":"6","author":"Watanabe","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2014.08.042_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.08.042_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.08.042_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.08.042_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ibd.21313","article-title":"Development, validation, and responsiveness of a novel disease activity index for intestinal Beh\u00e7et's disease","volume":"17","author":"Cheon","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2014.08.042_bib31","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.3748\/wjg.v18.i40.5771","article-title":"Correlations between endoscopic and clinical disease activity indices in intestinal Beh\u00e7et's disease","volume":"18","author":"Lee","year":"2012","journal-title":"World J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514013512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514013512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:17:03Z","timestamp":1761542223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356514013512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1542356514013512"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2014.08.042","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab for the Treatment of Japanese Patients With Intestinal Beh\u00e7et\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2014.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}